ArticleCureus2026
Assessment of Outcomes of Endonasal Dacryocystorhinostomy in a Tertiary Referral Center.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Surgical Outcomes of Revision Endoscopic Dacryocystorhinostomy with or Without Concomitant Septoplasty: A Retrospective Comparative Study.Medicina (Kaunas, Lithuania) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Chronic dacryocystitis due to nasolacrimal duct (NLD) obstruction is a common cause of epiphora and lacrimal abscess. Endonasal dacryocystorhinostomy (Endo-DCR) offers a scarless approach with outcomes comparable to those of external dacryocystorhinostomy when performed with appropriate technique and adequate follow-up. Objectives To evaluate the surgical outcomes of Endo-DCR and to identify risk factors associated with postoperative complications and surgical failure. Methods A retrospective observational study was conducted on 60 patients (18-70 years) with chronic dacryocystitis who underwent Endo-DCR. Follow-up data were collected at the end of one week, one month, three months, and six months following surgery. Success was defined as symptomatic resolution of epiphora with patent lacrimal syringing and endoscopic stomal patency at the end of six months. Fisher's exact test, independent t-test, and univariate binary logistic regression were used. P < 0.05 was considered significant. Results At the end of six months, patency on lacrimal sac syringing and stomal patency on endoscopy were seen in 78.3% (n = 47/60) of patients. Immediate complications were generally mild, including nasal bleeding in 3.3% (n = 2/60) and lid edema in 8.3% (5/60). Delayed complications included granulation tissue (8.3%, n = 5/60), synechiae (6.7%, n = 4/60), and stomal closure (6.7%, n = 4/60). Failure was associated with diabetes mellitus (DM) and deviated nasal septum (both p < 0.05). Deviated nasal septum (OR: 2.52) and DM (OR: 3.05) are predominant factors predicting failure. An additional insight from this study is the pattern seen with multiple concurrent risk factors. Combinations such as DM with smoking and DM with deviated nasal septum appeared to cluster among failures, suggesting a potential synergistic risk profile rather than purely additive effects. Conclusion Primary Endo-DCR achieved a high success rate in this tertiary center cohort. Deviated nasal septum and DM were associated with failure. Highlighting the importance of risk stratification, optimization of systemic disease, and concurrent management of nasal pathology to improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.